Cannabinoid immunoassay reagents

Ended Awarded Last action

Contract number
W91YTZ24F0169
Awardee
Awarding agency
Obligated
$12,645

Award facts

Contract value 100% obligated
$12,645.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6650 Optical Instruments, Test Equipment, Components And Accessories
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fort Meade, MD 20755, USA

Award details come from SAM.gov/FPDS.

About this award

Siemens Healthcare Diagnostics Inc. received a $12,645 firm fixed-price delivery order from the Defense Health Agency on June 25, 2024, for cannabinoid immunoassay reagents to support clinical laboratory operations at Fort Meade, Maryland. The contract, with an ultimate completion date of July 1, 2024, represents a child order under a larger federal procurement vehicle and was awarded without set-aside designation. Siemens Healthcare Diagnostics, a foreign-owned subsidiary of Germany-based Siemens Aktiengesellschaft and headquartered in Tarrytown, New York, is a leading provider of in vitro diagnostic solutions and laboratory services to the federal healthcare system, specializing in diagnostic equipment, analyzers, and specialized reagents for controlled substance screening and clinical testing.

This delivery order falls within the company's established portfolio of awards from the Defense Health Agency for laboratory diagnostic support, alongside previous significant orders for chemistry analyzers ($3.97 million), blood gas analyzers ($366,171.80), and fentanyl/norfentanyl testing reagents. The award reflects the company's demonstrated capabilities across multiple federal indefinite delivery vehicles, including a $49 million single-award Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical effective through April 2030 and a $22.8 million General Services Administration Federal Supply Schedule contract effective through November 2029, both of which enable streamlined procurement of laboratory equipment and consumables across the federal healthcare system.

Quick answers

Who was awarded contract W91YTZ24F0169?

W91YTZ24F0169 was awarded to Siemens Healthcare Diagnostics Inc. by Medical Command (Department of the Army) on June 25, 2024.

How much is contract W91YTZ24F0169 worth?

The government has obligated $12,645 on W91YTZ24F0169.

Which agency awarded contract W91YTZ24F0169?

Medical Command (Department of the Army) awarded W91YTZ24F0169, with funding from Defense Health Agency (Department of Defense).

Is contract W91YTZ24F0169 an order under another contract?

Yes. W91YTZ24F0169 is a delivery order under N6264521D5015, an indefinite delivery contract.

Was contract W91YTZ24F0169 competed?

The extent of competition for W91YTZ24F0169 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award